Onder Cinar
Research Subjects
Onder Cinar has a total of 217 co-authors. Here are the top co-authors by number of shared publications:
- Oktay Özman
Clinic of Urology, Memorial Bahçelievler Hospital, Istanbul, Turkey
22 shared publications - Murat Akgül
Umraniye Training & Research Hospital, Department of Urology, Health Sciences University, İstanbul, Turkey
20 shared publications - Cenk Murat Yazıcı
Department of Urology, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey
19 shared publications - Cem Basatac
Department of Urology, Demiroglu Bilim University, Istanbul, Turkey
17 shared publications - Mustafa Suat Bolat
Global Andrology Forum, Global Andrology Foundation, Moreland Hills, OH, USA
15 shared publications - Bulent Onal
Department of Urology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
12 shared publications
Latest Publications
- 10 August 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 553
The hidden half of premature ejaculation: partner factors and shared determinants: a couple-based cross-sectional study
- 10 August 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 553
The hidden half of premature ejaculation: partner factors and shared determinants: a couple-based cross-sectional study
- 28 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case–control study by the RIRSearch Study Group
- 28 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Outcomes of retrograde intrarenal surgery in patients on anticoagulant or antiplatelet therapy: a multicenter matched case–control study by the RIRSearch Study Group
- Open Access
- 21 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Effects of antifibrotic agent Nintedanib on experimentally generated priapism model in rats
Purpose This study investigated the effects of Nintedanib, a triple tyrosine kinase inhibitor, on cavernosal tissues in a rat model of ischemic priapism (IP), focusing on fibrosis and erectile function. Methods Sixty male Wistar Albino rats were divided into five groups (n = 12): Group 1 (control), Group 2 (1-hour IP + penectomy), Group 3 (1-hour IP + 6-week follow-up), Group 4 (1-hour IP + Nintedanib treatment for 6 weeks), and Group 5 (Nintedanib only). Erectile function was evaluated via intracavernosal pressure (ICP) during nerve stimulation. Fibrosis was assessed using Masson’s trichrome staining and immunohistochemistry for VEGFR-2, PDGFR-β, and FGF-1. Oxidative stress markers (MDA, GSH, SOD) and growth factors were analyzed via ELISA and spectrophotometry. Statistical analysis used Kruskal-Wallis and Mann-Whitney U tests (p < 0.05). Results Group 4 had significantly lower mean intracavernosal pressure (MeICP) values (median 26.5 mmHg) than Group 3 (49 mmHg) (p < 0.001). Masson’s trichrome showed highest fibrosis in Group 4 (score 3 [2–4]) compared to Group 3 (score 3 [1–4]) (p < 0.001). VEGFR-2 ELISA levels dropped in Group 4 (6.55 ng/mL [5.5–7.1]) vs. Group 3 (7.75 ng/mL [7–7.9]) (p < 0.001). MDA levels peaked in Group 4 (33.66 nmol/g [24.39–45.39]), while GSH values remained comparable between Groups 3 and 4. SOD increased significantly in Groups 2–4 (Group 4: 6.25 ng/mL [5.2–7.0]) compared to Group 1 (4.95 ng/mL [3.9–5.6]) (p < 0.001). Conclusion Although Nintedanib is antifibrotic in pulmonary contexts, it appears to promote penile fibrosis post-IP, likely via excessive VEGFR-2 inhibition, impairing vascular recovery and erectile function. Further studies are needed.
- 21 October 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-10
Open AccessEffects of antifibrotic agent Nintedanib on experimentally generated priapism model in rats
Purpose This study investigated the effects of Nintedanib, a triple tyrosine kinase inhibitor, on cavernosal tissues in a rat model of ischemic priapism (IP), focusing on fibrosis and erectile function. Methods Sixty male Wistar Albino rats were divided into five groups (n = 12): Group 1 (control), Group 2 (1-hour IP + penectomy), Group 3 (1-hour IP + 6-week follow-up), Group 4 (1-hour IP + Nintedanib treatment for 6 weeks), and Group 5 (Nintedanib only). Erectile function was evaluated via intracavernosal pressure (ICP) during nerve stimulation. Fibrosis was assessed using Masson’s trichrome staining and immunohistochemistry for VEGFR-2, PDGFR-β, and FGF-1. Oxidative stress markers (MDA, GSH, SOD) and growth factors were analyzed via ELISA and spectrophotometry. Statistical analysis used Kruskal-Wallis and Mann-Whitney U tests (p < 0.05). Results Group 4 had significantly lower mean intracavernosal pressure (MeICP) values (median 26.5 mmHg) than Group 3 (49 mmHg) (p < 0.001). Masson’s trichrome showed highest fibrosis in Group 4 (score 3 [2–4]) compared to Group 3 (score 3 [1–4]) (p < 0.001). VEGFR-2 ELISA levels dropped in Group 4 (6.55 ng/mL [5.5–7.1]) vs. Group 3 (7.75 ng/mL [7–7.9]) (p < 0.001). MDA levels peaked in Group 4 (33.66 nmol/g [24.39–45.39]), while GSH values remained comparable between Groups 3 and 4. SOD increased significantly in Groups 2–4 (Group 4: 6.25 ng/mL [5.2–7.0]) compared to Group 1 (4.95 ng/mL [3.9–5.6]) (p < 0.001). Conclusion Although Nintedanib is antifibrotic in pulmonary contexts, it appears to promote penile fibrosis post-IP, likely via excessive VEGFR-2 inhibition, impairing vascular recovery and erectile function. Further studies are needed.
- 1 October 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (10) , 792-797
The Impact of Preoperative JJ Stent Diameter on Retrograde Intrarenal Surgery: A RIRSearch Group Study
Introduction: A JJ stent placed before retrograde intrarenal surgery (RIRS) may passively dilate the ureter and facilitate ureteral access sheath (UAS) implantation. No studies have examined the significance of preoperative JJ stent diameter, even though numerous studies have shown that UAS insertion is simpler in patients with them. Our study examines the relationship between preoperative ureteral stent caliber and UAS placement and RIRS results. Materials and Methods: A total of 655 patients with known preoperative double-J stent size before RIRS were analyzed. The patients were categorized into two groups based on their preoperative stent diameter (Group 1: 4.8 Fr and Group 2: 6 Fr). Demographic and clinical data of the patients, stone characteristics, surgical data, perioperative and postoperative complications, duration of hospitalization, and stone-free rates (SFRs) were analyzed for comparison. Results: The groups contained 323 and 332 patients. The demographic data of the two groups were similar. There was no statistically significant difference between SFR, UAS insertion rate, hospitalization time, and complications. The success rate of placing a UAS with a higher caliber was statistically significantly higher in those with a 6 Fr JJ stent than in those with a 4.8 Fr stent ( P = .001 ). The operation time was also shorter in the group with a thicker stent ( P = .003 ). Conclusions: Our data suggest that while the preoperative JJ stent diameter does not significantly affect overall UAS insertion success, complication rates, or postoperative stone-free status, using a 6 Fr stent facilitates the placement of larger UAS calibers and may decrease operation time. Consequently, although both stent diameters are efficacious, selecting a 6 Fr stent may provide procedural benefits without jeopardizing safety or results.
- 1 October 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (10) , 792-797
The Impact of Preoperative JJ Stent Diameter on Retrograde Intrarenal Surgery: A RIRSearch Group Study
Introduction: A JJ stent placed before retrograde intrarenal surgery (RIRS) may passively dilate the ureter and facilitate ureteral access sheath (UAS) implantation. No studies have examined the significance of preoperative JJ stent diameter, even though numerous studies have shown that UAS insertion is simpler in patients with them. Our study examines the relationship between preoperative ureteral stent caliber and UAS placement and RIRS results. Materials and Methods: A total of 655 patients with known preoperative double-J stent size before RIRS were analyzed. The patients were categorized into two groups based on their preoperative stent diameter (Group 1: 4.8 Fr and Group 2: 6 Fr). Demographic and clinical data of the patients, stone characteristics, surgical data, perioperative and postoperative complications, duration of hospitalization, and stone-free rates (SFRs) were analyzed for comparison. Results: The groups contained 323 and 332 patients. The demographic data of the two groups were similar. There was no statistically significant difference between SFR, UAS insertion rate, hospitalization time, and complications. The success rate of placing a UAS with a higher caliber was statistically significantly higher in those with a 6 Fr JJ stent than in those with a 4.8 Fr stent ( P = .001 ). The operation time was also shorter in the group with a thicker stent ( P = .003 ). Conclusions: Our data suggest that while the preoperative JJ stent diameter does not significantly affect overall UAS insertion success, complication rates, or postoperative stone-free status, using a 6 Fr stent facilitates the placement of larger UAS calibers and may decrease operation time. Consequently, although both stent diameters are efficacious, selecting a 6 Fr stent may provide procedural benefits without jeopardizing safety or results.
- 6 June 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (11) , 3655-3665
Management and treatment variations in premature ejaculation: a nationwide survey by the Andrology Working Group of the Society of Urological Surgery in Turkey
Purpose This study aimed to evaluate the diagnostic and therapeutic approaches to premature ejaculation (PE), focusing on variations in clinical practices and guideline adherence. Methods A structured survey was anonymously distributed via Google Forms to 900 clinicians between April 30 and June 10, 2024, of whom 378 completed the questionnaire, yielding a response rate of 42%. Participants included urologists, andrologists, psychiatrists, and sexual psychotherapists. The questionnaire covered diagnostic criteria, laboratory investigations, treatment preferences, management strategies for comorbid conditions, along with attitudes toward behavioral and invasive interventions. Statistical analyses included descriptive statistics, chi-square, and Fisher’s exact tests. Results The study revealed marked variability in the diagnosis and treatment of PE. While the ISSM definition was the most commonly used guideline (40.5%), psychiatrists predominantly relied on DSM-5-TR criteria (88.2%). Laboratory testing, including testosterone and thyroid function evaluations, was employed by 54.2% of participants. Dapoxetine was the most preferred first-line therapy (31.2%), followed by behavioral therapies (20.6%) and local anesthetics (19.6%). For patients unresponsive to initial therapies, couple-based sexual psychotherapy (18.6%) and use of long-acting daily SSRIs (14.8%) were the most preferred second-line treatments. Combination therapies were widely adopted (89.1%), though their components varied significantly. Surgical and invasive treatments, such as hyaluronic acid injections, were rarely utilized (18.3%), with most physicians reserving them for refractory cases. Pelvic floor relaxation exercises were recommended by 72% of participants, while 87.5% endorsed behavioral therapies for PE. Conclusion This study revealed substantial variability in PE management, its multifaceted etiology and guideline limitations. The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction.
- 6 June 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (11) , 3655-3665
Management and treatment variations in premature ejaculation: a nationwide survey by the Andrology Working Group of the Society of Urological Surgery in Turkey
Purpose This study aimed to evaluate the diagnostic and therapeutic approaches to premature ejaculation (PE), focusing on variations in clinical practices and guideline adherence. Methods A structured survey was anonymously distributed via Google Forms to 900 clinicians between April 30 and June 10, 2024, of whom 378 completed the questionnaire, yielding a response rate of 42%. Participants included urologists, andrologists, psychiatrists, and sexual psychotherapists. The questionnaire covered diagnostic criteria, laboratory investigations, treatment preferences, management strategies for comorbid conditions, along with attitudes toward behavioral and invasive interventions. Statistical analyses included descriptive statistics, chi-square, and Fisher’s exact tests. Results The study revealed marked variability in the diagnosis and treatment of PE. While the ISSM definition was the most commonly used guideline (40.5%), psychiatrists predominantly relied on DSM-5-TR criteria (88.2%). Laboratory testing, including testosterone and thyroid function evaluations, was employed by 54.2% of participants. Dapoxetine was the most preferred first-line therapy (31.2%), followed by behavioral therapies (20.6%) and local anesthetics (19.6%). For patients unresponsive to initial therapies, couple-based sexual psychotherapy (18.6%) and use of long-acting daily SSRIs (14.8%) were the most preferred second-line treatments. Combination therapies were widely adopted (89.1%), though their components varied significantly. Surgical and invasive treatments, such as hyaluronic acid injections, were rarely utilized (18.3%), with most physicians reserving them for refractory cases. Pelvic floor relaxation exercises were recommended by 72% of participants, while 87.5% endorsed behavioral therapies for PE. Conclusion This study revealed substantial variability in PE management, its multifaceted etiology and guideline limitations. The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction.
- 13 May 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (12) , 3985-3992
The comparison of efficacy and safety of reusable and disposable-flexible ureteroscopes: case-control matching results of multicentric RIRSearch study group
Purpose Today, disposable flexible ureteroscopes are increasingly used in retrograde intrarenal surgery (RIRS) as an alternative to reusable flexible ureteroscopes. The comparison of the safety and effectiveness of these two devices is still a matter of debate. This study evaluates the efficacy and safety of disposable-flexible ureteroscopes vs reusable flexible ureteroscopes in RIRS. Materials and methods The study included 1165 RIRS cases, and the patients were divided into two groups. Group 1 consisted of cases with reusable RIRS, 838 in total, while Group 2 consisted of disposable RIRS cases, 327 in total. Due to significant differences, case–control matching was performed, and subsequently, there were 229 patients in both groups. The demographic and clinical data of patients, stone characteristics, surgical data, perioperative and postoperative complications, postoperative urinary tract infection rate, duration of hospitalization, and stone-free rates (SFR) were analyzed and compared. Results No demographic differences were observed between the two groups after case–control matching. While operative time, SFR, and postoperative infection rates were similar between the groups (p > 0.05), fluoroscopy (p = 0.001) and hospitalization (p = 0.029) times were statistically significantly lower in the disposable ureteroscopy group. Perioperative and postoperative complications were also lower in this group (p = 0.018 and p = 0.001 respectively). Conclusion Our research indicates that single-use ureteroscopes are a strong alternative to reusable ureteroscopes, demonstrating similar efficacy and reduced complication rates in the treatment of upper urinary tract stones.
- 13 May 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (12) , 3985-3992
The comparison of efficacy and safety of reusable and disposable-flexible ureteroscopes: case-control matching results of multicentric RIRSearch study group
Purpose Today, disposable flexible ureteroscopes are increasingly used in retrograde intrarenal surgery (RIRS) as an alternative to reusable flexible ureteroscopes. The comparison of the safety and effectiveness of these two devices is still a matter of debate. This study evaluates the efficacy and safety of disposable-flexible ureteroscopes vs reusable flexible ureteroscopes in RIRS. Materials and methods The study included 1165 RIRS cases, and the patients were divided into two groups. Group 1 consisted of cases with reusable RIRS, 838 in total, while Group 2 consisted of disposable RIRS cases, 327 in total. Due to significant differences, case–control matching was performed, and subsequently, there were 229 patients in both groups. The demographic and clinical data of patients, stone characteristics, surgical data, perioperative and postoperative complications, postoperative urinary tract infection rate, duration of hospitalization, and stone-free rates (SFR) were analyzed and compared. Results No demographic differences were observed between the two groups after case–control matching. While operative time, SFR, and postoperative infection rates were similar between the groups (p > 0.05), fluoroscopy (p = 0.001) and hospitalization (p = 0.029) times were statistically significantly lower in the disposable ureteroscopy group. Perioperative and postoperative complications were also lower in this group (p = 0.018 and p = 0.001 respectively). Conclusion Our research indicates that single-use ureteroscopes are a strong alternative to reusable ureteroscopes, demonstrating similar efficacy and reduced complication rates in the treatment of upper urinary tract stones.
- 1 April 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (4) , 271-276
Does the 5-Item Modified Frailty Index Predict Adverse Outcomes after Retrograde Intrarenal Surgery? A Case—Control Study by the RIRSearch Group
Objectives: We aim to assess whether severely frail patients have an increased risk of complications and worse surgical outcomes after retrograde intrarenal surgery. Methods: The data of 340 consecutive patients undergoing retrograde intrarenal surgery to treat upper tract urinary stones were analyzed retrospectively. The 5-item modified frailty index (mFI-5) was used to assess the frailty status. Using a cutoff value of score 2 in the mFI-5 score, patients were divided into two groups: patients with an mFI-5 score Results: After matching confounding factors, Group 1 comprised 255 patients, and Group 2 comprised 85 patients. The baseline characteristics were similar between the groups. There were no statistically significant differences in terms of the median operation time and length of hospital stay among groups. There were no significant differences between groups for intraoperative complication rates (7.6% and 9.4%, respectively; P = .47) and postoperative complication rates (13.8% and 11.8%, respectively; P = .71), and stone-free rates (70.9% versus 72.9%, respectively; P = .73). Conclusions: Retrograde intrarenal surgery is an efficient and feasible treatment option for upper urinary tract stones in severely frail patients.
- 1 April 2025
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 35 (4) , 271-276
Does the 5-Item Modified Frailty Index Predict Adverse Outcomes after Retrograde Intrarenal Surgery? A Case—Control Study by the RIRSearch Group
Objectives: We aim to assess whether severely frail patients have an increased risk of complications and worse surgical outcomes after retrograde intrarenal surgery. Methods: The data of 340 consecutive patients undergoing retrograde intrarenal surgery to treat upper tract urinary stones were analyzed retrospectively. The 5-item modified frailty index (mFI-5) was used to assess the frailty status. Using a cutoff value of score 2 in the mFI-5 score, patients were divided into two groups: patients with an mFI-5 score Results: After matching confounding factors, Group 1 comprised 255 patients, and Group 2 comprised 85 patients. The baseline characteristics were similar between the groups. There were no statistically significant differences in terms of the median operation time and length of hospital stay among groups. There were no significant differences between groups for intraoperative complication rates (7.6% and 9.4%, respectively; P = .47) and postoperative complication rates (13.8% and 11.8%, respectively; P = .71), and stone-free rates (70.9% versus 72.9%, respectively; P = .73). Conclusions: Retrograde intrarenal surgery is an efficient and feasible treatment option for upper urinary tract stones in severely frail patients.
- 2 January 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-9
Can we predict postoperative fever and urinary tract ınfection after retrograde ıntrarenal surgery? Results of a case control matching multicentric RIRSearch study group
Purpose Postoperative fever (POF)/urinary tract infection (UTI) is one of the most unpleasant and undesirable conditions for surgeons after retrograde intrarenal surgery (RIRS). RIRS is not recommended for any patient with a positive urine culture to avoid POF and UTI, but some patients may develop postoperative UTI even if the urine culture is sterile. This study investigated the predictive factors of fever and UTIs after RIRS. Methods In total, 1240 patients who underwent RIRS for proximal ureteral stones and/or kidney stones were analyzed. After case-control matching, 168 patients were included in the study. Demographic data, preoperative/peroperative/postoperative data, and hematological parameters were compared. Patients with sterile urine cultures were included in the study. Postoperative fever was defined as fever ≥ 38 °C within 72 h after RIRS. Patients were divided into two groups: those with and without POF/UTI. Demographic data, preoperative and postoperative findings, and inflammatory parameters of the patients were compared retrospectively. Results POF/UTI was observed in 61 (36.3%) of 168 patients who underwent RIRS. After case-control matching, increased body mass index (BMI) and longer operation time were found to be significant predictors of POF/UTI (p = 0.001 and 0.016 respectively). Preoperative systemic immune-inflammation index (SII) (PxN/L), high Platelet/Lymphocyte Ratio (PLR), and urine leukocyte positivity were found to be significant predictors of POF/UTI (p = 0.037, 0.025 and 0.038 respectively). Conclusion Hematological parameters are simple and feasible to use to evaluate POF/UTI in patients undergoing RIRS. High SII and PLR may predict POF and early infection after RIRS. In addition, according to demographic data and per-operative status, high BMI and prolonged operation time are risk factors for infection.
- 2 January 2025
- Published by Springer Nature in World Journal of Urology
- Vol. 43 (1) , 1-9
Can we predict postoperative fever and urinary tract ınfection after retrograde ıntrarenal surgery? Results of a case control matching multicentric RIRSearch study group
Purpose Postoperative fever (POF)/urinary tract infection (UTI) is one of the most unpleasant and undesirable conditions for surgeons after retrograde intrarenal surgery (RIRS). RIRS is not recommended for any patient with a positive urine culture to avoid POF and UTI, but some patients may develop postoperative UTI even if the urine culture is sterile. This study investigated the predictive factors of fever and UTIs after RIRS. Methods In total, 1240 patients who underwent RIRS for proximal ureteral stones and/or kidney stones were analyzed. After case-control matching, 168 patients were included in the study. Demographic data, preoperative/peroperative/postoperative data, and hematological parameters were compared. Patients with sterile urine cultures were included in the study. Postoperative fever was defined as fever ≥ 38 °C within 72 h after RIRS. Patients were divided into two groups: those with and without POF/UTI. Demographic data, preoperative and postoperative findings, and inflammatory parameters of the patients were compared retrospectively. Results POF/UTI was observed in 61 (36.3%) of 168 patients who underwent RIRS. After case-control matching, increased body mass index (BMI) and longer operation time were found to be significant predictors of POF/UTI (p = 0.001 and 0.016 respectively). Preoperative systemic immune-inflammation index (SII) (PxN/L), high Platelet/Lymphocyte Ratio (PLR), and urine leukocyte positivity were found to be significant predictors of POF/UTI (p = 0.037, 0.025 and 0.038 respectively). Conclusion Hematological parameters are simple and feasible to use to evaluate POF/UTI in patients undergoing RIRS. High SII and PLR may predict POF and early infection after RIRS. In addition, according to demographic data and per-operative status, high BMI and prolonged operation time are risk factors for infection.
- 21 December 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (5) , 1425-1431
The effects of microsurgical varicocelectomy performed for infertility on premature ejaculation
Purpose To investigate the effects of varicocelectomy on premature ejaculation (PE) in patients with varicocele and infertility. Methods A total of 82 sexually active patients aged 18 years or over who had undergone microscopic subinguinal varicocelectomy with a clinical diagnosis of varicocele in 14 urology clinics between October 2021 and March 2023 with primary infertility were evaluated prospectively Patients were evaluated using the Turkish validated form of the ‘Premature Ejaculation Diagnostic Tool’ (PEDT) scale. A PEDT score of 11 or above was taken to indicate the presence of PE. Turkish validated forms of PEDT and International Index of Erectile Function-5 (IIEF-5) were completed in all patients pre-operatively and at 3 and 6 months post-operatively. Intravaginal ejaculatory latency time (IELT) and serum testosterone measurements were also recorded. Results Left varicocelectomy was performed in 70.7% and bilateral varicocelectomy in 29.3% of the participants. A significant difference was found between pre- and post-operative PEDT scores (× 2 (2) = 130.1, p < 0.001). A significant difference was observed between pre- and post-operative IELT time (× 2 (2) = 143.2, p < 0.001). IIEF-5 scores differed before and after surgery (× 2 (2) = 59.5, p < 0.001). A difference was found between the testosterone levels measured before and after surgery (× 2 (2) = 40.9, p < 0.001). No statistically significant difference was observed between the third- and sixth-month testosterone values (p = 0.183). Testosterone levels (p = 0.001) and IELT scores (p < 0.001) were significantly higher, while PEDT scores (p < 0.001) were significantly lower in the bilateral varicocelectomy group at the sixth post-operative month. Conclusion In light of our findings, it is recommended that infertile patients with varicocele be informed of the positive effects of varicocelectomy on PE.
- 21 December 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (5) , 1425-1431
The effects of microsurgical varicocelectomy performed for infertility on premature ejaculation
Purpose To investigate the effects of varicocelectomy on premature ejaculation (PE) in patients with varicocele and infertility. Methods A total of 82 sexually active patients aged 18 years or over who had undergone microscopic subinguinal varicocelectomy with a clinical diagnosis of varicocele in 14 urology clinics between October 2021 and March 2023 with primary infertility were evaluated prospectively Patients were evaluated using the Turkish validated form of the ‘Premature Ejaculation Diagnostic Tool’ (PEDT) scale. A PEDT score of 11 or above was taken to indicate the presence of PE. Turkish validated forms of PEDT and International Index of Erectile Function-5 (IIEF-5) were completed in all patients pre-operatively and at 3 and 6 months post-operatively. Intravaginal ejaculatory latency time (IELT) and serum testosterone measurements were also recorded. Results Left varicocelectomy was performed in 70.7% and bilateral varicocelectomy in 29.3% of the participants. A significant difference was found between pre- and post-operative PEDT scores (× 2 (2) = 130.1, p < 0.001). A significant difference was observed between pre- and post-operative IELT time (× 2 (2) = 143.2, p < 0.001). IIEF-5 scores differed before and after surgery (× 2 (2) = 59.5, p < 0.001). A difference was found between the testosterone levels measured before and after surgery (× 2 (2) = 40.9, p < 0.001). No statistically significant difference was observed between the third- and sixth-month testosterone values (p = 0.183). Testosterone levels (p = 0.001) and IELT scores (p < 0.001) were significantly higher, while PEDT scores (p < 0.001) were significantly lower in the bilateral varicocelectomy group at the sixth post-operative month. Conclusion In light of our findings, it is recommended that infertile patients with varicocele be informed of the positive effects of varicocelectomy on PE.